Chun-Yu Liu
Overview
Explore the profile of Chun-Yu Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
274
Citations
4484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin T, Tseng Y, Dong M, Lin C, Chung W, Liu C, et al.
Clin Epigenetics
. 2025 Feb;
17(1):37.
PMID: 40012020
Breast cancer has constantly been the leading causes of death in women, and hormone receptor (HR) positive, HER2 negative is the majority subtype. Histone deacetylase (HDAC) inhibitors (HDACi) have shown...
2.
Ho I, Tseng Y, Liu C, Tsai Y, Huang C, Tseng L, et al.
J Cancer
. 2025 Feb;
16(5):1726-1735.
PMID: 39991566
Despite rapidly improving therapeutics, challenges remain in the treatment of advanced breast cancer. Vinorelbine, a semisynthetic vinca alkaloid, is effective and well-tolerated in breast cancer treatment. The combination of vinorelbine...
3.
Dong Y, Liu C, Shi W, Guan Z, Wang Q
Angew Chem Int Ed Engl
. 2025 Jan;
64(9):e202420314.
PMID: 39853822
Open metal sites are crucial in catalysis. We have used a "loose coordination strategy" (LCS) to preorganize open metal sites in gold cluster catalysts. A gold nanocluster with composition of...
4.
Tsai Y, Lai J, Liu C, Hsi C, Hsu C, Huang C, et al.
World J Oncol
. 2025 Jan;
16(1):131-141.
PMID: 39850525
Background: While mutations in the gene play important roles in human breast carcinogenesis, gene alterations are recognized as actionable mutations for clinical cancer treatment. We aimed to elucidate the role...
5.
Kao Y, Tsai Y, Shen S, Dai M, Chen F, Liu L, et al.
J Chin Med Assoc
. 2024 Nov;
88(1):26-33.
PMID: 39528456
Background: Everolimus was the first orally targeted therapy for certain cancers. It was introduced before CDK4/6 inhibitors and is widely used to treat advanced hormone receptor-positive (HR+)/human epidermal growth factor...
6.
Yang T, Tsai C, Wang H, Ko P, Chien S, Lin T, et al.
Ann Hematol
. 2024 Sep;
103(11):4661-4670.
PMID: 39223286
Hematopoietic stem cell transplantation (HSCT) is pivotal in treating hematologic disorders, yet it poses the risk of post-transplantation pancytopenia. Prophylactic platelet transfusions are often administered to mitigate this risk. Utilizing...
7.
Chen B, Tsai Y, Chao T, Lien P, Lin Y, Feng C, et al.
Clin Exp Med
. 2024 Aug;
24(1):185.
PMID: 39133334
Purpose: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy have demonstrated significant clinical benefits in progression-free and overall survival. This study investigates the outcomes associated with two kinds of...
8.
Yu C, Cong Y, Wei J, Guo B, Liu C, Liao Y
Colloids Surf B Biointerfaces
. 2024 Jun;
241:113989.
PMID: 38838444
Icariin has been shown the promising therapeutic potential to treat inflammatory airway diseases, yet its poor lung distribution and retention restrict the clinical applications. To this end, this work aimed...
9.
Lee C, Yu T, Lin F, Hung G, Hou M, Ho C, et al.
Cytotherapy
. 2024 May;
26(10):1201-1209.
PMID: 38795116
Autologous peripheral blood stem cell (PBSC) transplantation is crucial in pediatric cancer treatment, and tandem transplantation is beneficial in certain malignancies. Collecting PBSCs in small children with low body weight...
10.
Zhao H, Liu C, Meng H, Sun C, Yang H, Wang H, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793564
Porcine reproductive and respiratory syndrome virus (PRRSV) is a pathogen that causes severe abortions in sows and high piglet mortality, resulting in huge economic losses to the pig industry worldwide....